Jfe Steel Corporation

The Noguchi Institute

Ichiro Sugimoto

Shuji Kawamura

Takeshi Yokota

Hideyuki Kimura

Shunsuke Toyoda

Junko Amano

Makoto Asai

Kiyoko Hirano

Provided are a hot-rolled steel sheet for coiled tubing and a method for manufacturing the steel sheet. The steel sheet has a yield strength of 480 MPa or more, a tensile strength of 600 MPa or more, a yield-strength difference (&#x394;YS) of 100 MPa or more, where the yield-strength difference is defined as a difference in yield strength between before and after a prestrain-heat treatment performed for simulation of a tube-making process and a stress-relief annealing heat treatment which are currently implemented, and a yield strength of 620 MPa or more after the prestrain-heat treatment.

Hot-rolled steel sheet for coiled tubing and method for manufacturing the same

A steel member, a hot-rolled steel sheet to be used as a material thereof, and production methods therefor are provided. A steel member contains 0.010% to 0.120% Ti, in which 0.005% or more of Ti is precipitated as a precipitate having a particle size of 20 nm or less in the microstructure. A hot-rolled steel sheet for the steel member contains 0.010% to 0.120% Ti, in which 0.005% or more of Ti is present as dissolved Ti in the microstructure. A method for producing the steel member includes subjecting a hot-rolled steel sheet to forming processing and then performing heat treatment including heating to a temperature of higher than 550&#xb0; C. and 1,050&#xb0; C. or lower and then cooling at an average cooling rate of 10&#xb0; C./s or more in the temperature range of 550&#xb0; C. to 400&#xb0; C.

Steel member and production method therefor

The present invention provides a method for accurately discriminating between prostate carcinoma and benign prostatic hyperplasia based on a glycan structure of prostate specific antigen (PSA). The method of the present invention includes the steps of: purifying PSA from a sample derived from a subject; preparing a PSA derivative from the PSA; labeling the PSA derivative; and analyzing the labeled PSA derivative by the mass spectrometry method, in which the subject is identified as having prostate carcinoma when the ratio of the signal intensity of fucose-unbound glycan to the signal intensity of fucose-bound glycan in the labeled PSA derivative is greater than 1.0, and identified as having benign prostatic hyperplasia when the ratio is 1.0 or less.

Method for discriminating between prostatic cancer and benign prostatic hyperplasia

Growing community of inventors

Tokyo, Japan

Ichiro Sugimoto